Perceptions regarding vasopressin use and practices in septic shock, and cost containment strategies.

Drayton A Hammond Megan A RechMitchell J DaleyJohn W DevlinEmily K HodgeKirstin J KoodaIshaq LatHeather A PersonettRussel RobertsGretchen L SachaJoanna L StollingsJoseph M SwansonSeth R Bauer

Published in: Journal of the American College of Clinical Pharmacy : JACCP (2019)

Since vasopressin was generically rebranded, most institutions have implemented at least one initiative to reduce vasopressin use and/or educate clinicians about its appropriate use. When vasopressin acquisition costs were considered, pharmacists recommended its use less frequently, particularly in clinical scenarios where its use is controversial.

Keyphrases

septic shock
healthcare
primary care
climate change
palliative care
general practice